Chief Executive Officer of Biomarin Pharmaceutical Inc (NASDAQ:BMRN), Bienaime Jean Jacques, sells 7,000 shares worth $595,560
According to Biomarin Pharmaceutical Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 19 09:22 PM, company Chief Executive Officer, Bienaime Jean Jacques disclosed selling 7,000 shares at a cost of $85.08. At the time of this transaction (Feb 18), this trade was worth $595,560 in total. As of Feb 18, Bienaime Jean Jacques now owns 295,552 shares in total worth about $24,164,331.520000003.
For the last few recent trades made by Biomarin Pharmaceutical Inc (NASDAQ:BMRN) Chief Executive Officer, Bienaime Jean Jacques, we have the following information:
- SEC Form 4 filing: Feb 17: Sold 8,000 shares at the rate of $84.54 per share. Total worth of this trade was $676,320. Total number of shares owned as of Feb 17 were 295,552
- SEC Form 4 filing: Jan 28: Sold 8,333 shares at the rate of $82.91 per share. Total worth of this trade was $690,889. Total number of shares owned as of Jan 28 were 295,552
- SEC Form 4 filing: Jan 29: Sold 8,334 shares at the rate of $82.67 per share. Total worth of this trade was $688,972. Total number of shares owned as of Jan 29 were 295,552
Posted by
George Daniels
on Saturday February 20 2021, 8:45 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
